Along with the idea that crippling UPR signaling could be an effective way to stop ALS, SOD1G86R transgenic lacking ATF4 displayed an altered management of SOD1 protein aggregates and delayed disease onset as well as slightly improved survival [121]. This evidence concerns the gene ATF4 and amyotrophic lateral sclerosis.